company-logo

AXIM Biotechnologies, Inc. develops and sells diagnostic healthcare solutions in the areas of SARS-CoV-2, eye health, and oncology. The company is developing rapid diagnostic tests, which measure the levels of functional neutralizing antibodies that prevent SARS-CoV-2 from attaching to human cells; serological diagnostic test, which detect neutralizing antibodies that measure adaptive immune response to the SARS-CoV-2 virus; and tests for management of COVID-19 Patients to detect biomarkers related to inflammation. It is also developing rapid quantitative tear tests for Matrix metalloproteinase-9, an inflammatory biomarker for dry eye disease; SBI-183, an anti-metastatic compound suppressing tumor cell growth and blocking metastasis; and SPX-1009, an anti-metastatic treatment to measure levels of quiescin sulfhydryl oxidase I. The company was formerly known as Axim International Inc. and changed its name to AXIM Biotechnologies, Inc. in July 2014. AXIM Biotechnologies, Inc. was incorporated in 2010 and is based in San Diego, California.

AXIM Biotechnologies Dividend Announcement

AXIM Biotechnologies does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
Stay tuned for updates on AXIM Biotechnologies dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

AXIM Biotechnologies Dividend History

AXIM Biotechnologies Dividend Yield

AXIM Biotechnologies current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing AXIM Biotechnologies stock? Use our calculator to estimate your expected dividend yield:

AXIM Biotechnologies Financial Ratios

P/E ratio-0.27
PEG ratio0.07
P/B ratio-0.12
ROE54.15%
Payout ratio0.00%
Current ratio0.00
Quick ratio0.00
Cash Ratio0.00

AXIM Biotechnologies Dividend FAQ

Does AXIM Biotechnologies stock pay dividends?
AXIM Biotechnologies does not currently pay dividends to its shareholders.
Has AXIM Biotechnologies ever paid a dividend?
No, AXIM Biotechnologies has no a history of paying dividends to its shareholders. AXIM Biotechnologies is not known for its dividend payments.
Why doesn't AXIM Biotechnologies pay dividends?
There are several potential reasons why AXIM Biotechnologies would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will AXIM Biotechnologies ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While AXIM Biotechnologies has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is AXIM Biotechnologies a dividend aristocrat?
AXIM Biotechnologies is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is AXIM Biotechnologies a dividend king?
AXIM Biotechnologies is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is AXIM Biotechnologies a dividend stock?
No, AXIM Biotechnologies is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy AXIM Biotechnologies stocks?
To buy AXIM Biotechnologies you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy AXIM Biotechnologies stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.